National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Pancreatic Cancer Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 07/31/2008



Purpose of This PDQ Summary






General Information






Cellular Classification






Stage Information






Treatment Option Overview






Stage I and II Pancreatic Cancer






Stage III Pancreatic Cancer






Stage IV Pancreatic Cancer






Recurrent Pancreatic Cancer






Get More Information From NCI






Changes to This Summary (07/31/2008)






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Cellular Classification

Pancreatic cancer includes the following carcinomas:

Malignant

  • Duct cell carcinoma (90% of all cases).
  • Acinar cell carcinoma.
  • Papillary mucinous carcinoma.
  • Signet ring carcinoma.
  • Adenosquamous carcinoma.
  • Undifferentiated carcinoma.
  • Mucinous carcinoma.
  • Giant cell carcinoma.
  • Mixed type (ductal-endocrine or acinar-endocrine).
  • Small cell carcinoma.
  • Cystadenocarcinoma (serous and mucinous types).
  • Unclassified.
  • Pancreatoblastoma.
  • Papillary-cystic neoplasm (Frantz tumor). (This tumor has lower malignant potential and may be cured with surgery alone.)[1,2]
  • Invasive adenocarcinoma associated with cystic mucinous neoplasm or intraductal papillary mucinous neoplasm.

Borderline Malignancies

  • Mucinous cystic tumor with dysplasia.
  • Intraductal papillary mucinous tumor with dysplasia.[3]
  • Pseudopapillary solid tumor.

References

  1. Sanchez JA, Newman KD, Eichelberger MR, et al.: The papillary-cystic neoplasm of the pancreas. An increasingly recognized clinicopathologic entity. Arch Surg 125 (11): 1502-5, 1990.  [PUBMED Abstract]

  2. Warshaw AL, Compton CC, Lewandrowski K, et al.: Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann Surg 212 (4): 432-43; discussion 444-5, 1990.  [PUBMED Abstract]

  3. Sohn TA, Yeo CJ, Cameron JL, et al.: Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg 234 (3): 313-21; discussion 321-2, 2001.  [PUBMED Abstract]

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov